Cargando…

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine

Vasopressor agents are often used in patients with septic shock when aggressive fluid resuscitation fails to correct hypotension. Dopamine and norepinephrine are two such vasopressor agents. In the past, fear of potential excessive vasoconstriction, with resultant end-organ hypoperfusion, restricted...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Vinay K, Dellinger, R Phillip
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154108/
https://www.ncbi.nlm.nih.gov/pubmed/12617728
http://dx.doi.org/10.1186/cc1835
_version_ 1782120734732058624
author Sharma, Vinay K
Dellinger, R Phillip
author_facet Sharma, Vinay K
Dellinger, R Phillip
author_sort Sharma, Vinay K
collection PubMed
description Vasopressor agents are often used in patients with septic shock when aggressive fluid resuscitation fails to correct hypotension. Dopamine and norepinephrine are two such vasopressor agents. In the past, fear of potential excessive vasoconstriction, with resultant end-organ hypoperfusion, restricted the use of norepinephrine in septic shock, relegating it to a second-line agent. However, recent data suggest that this relegation is unmerited and that norepinephrine may even be superior to dopamine in some respects, and should be considered as the preferred first-line agent. In the present commentary we review the evidence supporting the use of norepinephrine as the agent of choice in the treatment of septic shock.
format Text
id pubmed-154108
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1541082003-05-06 The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine Sharma, Vinay K Dellinger, R Phillip Crit Care Commentary Vasopressor agents are often used in patients with septic shock when aggressive fluid resuscitation fails to correct hypotension. Dopamine and norepinephrine are two such vasopressor agents. In the past, fear of potential excessive vasoconstriction, with resultant end-organ hypoperfusion, restricted the use of norepinephrine in septic shock, relegating it to a second-line agent. However, recent data suggest that this relegation is unmerited and that norepinephrine may even be superior to dopamine in some respects, and should be considered as the preferred first-line agent. In the present commentary we review the evidence supporting the use of norepinephrine as the agent of choice in the treatment of septic shock. BioMed Central 2003 2002-11-01 /pmc/articles/PMC154108/ /pubmed/12617728 http://dx.doi.org/10.1186/cc1835 Text en Copyright © 2003 BioMed Central Ltd
spellingShingle Commentary
Sharma, Vinay K
Dellinger, R Phillip
The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title_full The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title_fullStr The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title_full_unstemmed The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title_short The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
title_sort international sepsis forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154108/
https://www.ncbi.nlm.nih.gov/pubmed/12617728
http://dx.doi.org/10.1186/cc1835
work_keys_str_mv AT sharmavinayk theinternationalsepsisforumscontroversiesinsepsismyinitialvasopressoragentinsepticshockisnorepinephrineratherthandopamine
AT dellingerrphillip theinternationalsepsisforumscontroversiesinsepsismyinitialvasopressoragentinsepticshockisnorepinephrineratherthandopamine
AT sharmavinayk internationalsepsisforumscontroversiesinsepsismyinitialvasopressoragentinsepticshockisnorepinephrineratherthandopamine
AT dellingerrphillip internationalsepsisforumscontroversiesinsepsismyinitialvasopressoragentinsepticshockisnorepinephrineratherthandopamine